Profil
Jan Tadeusz Czernuszka is the founder of Oxtex Ltd.
which was founded in 2011, where he holds the title of Chief Technical Officer & Director.
Currently, he holds the position of Head-Biomaterials Group at the University of Oxford and Dean & Vice President at Trinity College (Oxford).
Dr. Czernuszka's education history includes a graduate degree from the University of Oxford, an undergraduate degree from Imperial College London, and a doctorate from the University of Cambridge.
Aktive Positionen von Jan Tadeusz Czernuszka
Unternehmen | Position | Beginn |
---|---|---|
Oxtex Ltd.
Oxtex Ltd. Medical SpecialtiesHealth Technology Oxtex Ltd. operates as an early-stage medical device company. It develops novel devices for soft tissue expansion. The firm's technology comprises implantable self-inflating tissue expanders available in sizes and shapes to suit the specific needs of the clinician and the patient. The company was founded by Jan Tadeusz Czernuszka and David Edward Jackson in May 2011 and is headquartered in Witney, the United Kingdom. | Gründer | 01.05.2011 |
University of Oxford | Corporate Officer/Principal | - |
Trinity College (Oxford) | Corporate Officer/Principal | - |
Ausbildung von Jan Tadeusz Czernuszka
University of Oxford | Graduate Degree |
Imperial College London | Undergraduate Degree |
University of Cambridge | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Oxtex Ltd.
Oxtex Ltd. Medical SpecialtiesHealth Technology Oxtex Ltd. operates as an early-stage medical device company. It develops novel devices for soft tissue expansion. The firm's technology comprises implantable self-inflating tissue expanders available in sizes and shapes to suit the specific needs of the clinician and the patient. The company was founded by Jan Tadeusz Czernuszka and David Edward Jackson in May 2011 and is headquartered in Witney, the United Kingdom. | Health Technology |